RNAseq-based data have revealed that irisin affects multiple genes related to the SARS-CoV-2 infection in human subcutaneous adipocytes (91), suggesting that the potential beneficial effects of irisin on COVID-19 outcomes are beyond its anti-inflammatory action on macrophages. This evidence concerns the gene FNDC5 and COVID-19.